A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization led ...

A bankruptcy court approved the $305M sale of 23andMe to a nonprofit led by Anne Wojcicki, raising questions about data ...

That means Wojcicki’s nonprofit TTAM Research Institute will purchase “substantially all” of San Francisco-based 23andMe’s ...

Customer Notification: With 23andMe’s cooperation, all customers will be emailed at least two business days before closing with details on TTAM’s role, TTAM’s commitment to privacy choices ...

23andMe Holding Co. will be sold to TTAM Research Institute, a genetics-led healthcare company based in California and led by ...

Moelis & Company LLC is serving as investment banker to the Special Committee of 23andMe’s Board of Directors. Reevemark and Scale are serving as communications advisors to the Company.

Despite the company falling into bankruptcy, Mark Jensen, chair of the board and member of the Special Committee of the Board of Directors of 23andMe, commended Wojcicki, saying she is "well ...

San Francisco-based 23andMe filed for Chapter 11 bankruptcy protection in the Eastern Missouri federal court district in ...

Wojcicki had tried unsuccessfully to take the company private, but her proposals were rejected by a special committee formed by 23andMe’s board of directors.

From the San Francisco Business Times. 23andMe co-founder Anne Wojcicki is back in control of the genetic-testing company. A nonprofit led by Wojcicki — who launched the consumer DNA-test ...

SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering ...